Artificial Intelligence: Difference between revisions

Revision as of 18:46, 7 July 2017

Cardiogram: Ex-google founders, applying deep learning to mobile health data. Backed by Andreessen Horowitz.
Neura: Using AI to optimize mobile apps and IoT devices for Med adherence. Interesting SDK approach. Raised $13M. Israeli team, located in Sunnyvale.
Enlitic: SF-based, $15M raised. Applying deep-learning to areas like triage, radiology, screening.
Deep6: AI-based text analysis of EHRs to find clinical trial candidates. ? Funding.
Digital Reasoning: Cognitive computing applied to industries. Healthcare focus. $73.9M raised.
PhysIQ: ML applied to biosignals to create a personal baseline. Selling to post-acute providers, pharma (clinical trials), wearable/device manufacturers. $11.9M raised.
DreaMed Diabetes: $5.3M raised from Medtronic. Closed-loop insulin delivery tech. CE mark for artificial pancreas.
Roam Analytics: ML platform for various applications in healthcare. $21M raised.
Hindsait: Various applications of NLP, ML in Healthcare. Unknown funding.

Zebra Med: AI applied to medical imaging. $20M raised. Israeli.
Jvion: Cognitive computing applied to clinical data to make various predictions. $9M raised.
AI Cure: Applying machine learning and computer vision to medication adherence. Smartphone camera can verify if the patient took medication. Raised $15M+.
Gauss Surgical: $24M raised. Computer vision and AI for measuring blood loss during surgery. Since 2011.
BayLabs: Applying deep learning to ultrasound imaging. $5.3M Series A.
Aidence: Medical image analysis. Amsterdam. $2.5M raised.

Fathom Health: Applying AI and deep learning NLP to reimbursement. Formerly TinyRx (on-demand prescription delivery service, shut down in May 2016). Raised $7.7M. Google ventures included.
CloudMedX: $6.7M raised. Billing optimization.

Atomwise: Drug discovery using AI. Raised $6M+
Recursion Pharmaceuticals: Drug discovery using AI. $58M raised.
Benevolent.ai: AI for drug discovery and bioscience innovation in general. $140M raised. UK based.
GNS Healthcare: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised.
Berg: Unknown funding. Therapy discovery using omics data.
Turbine: Cancer therapeutics using AI. Unknown funding. EU.

KenSci: Risk stratification of patient populations using ML. UW Tacoma professor founder. $8.5M raised.
Lumiata: Healthcare risk management using AI. $20M raised. Khosla Ventures.

Your MD: AI-driven chatbot that does lead gen for care services. $7.3M funded. London based.
Buoy: $2M raised. Adam Grant (Author) is founder.
Babylon Health: $25M raised. UK.
Elth: India-based

Deep Genomics: Using ML to predict effects of genetic variation on a disease context. $3.7M raised. Canadian.

@@ Line 24: / Line 24: @@
 == Therapy Discovery ==
 *[http://www.atomwise.com/ Atomwise]: Drug discovery using AI. Raised $6M+
-*[http://www.recursionpharma.com/approach.html Recursion Pharmaceuticals]: Drug discovery using AI. $13.2M in 3 rounds.
+*[http://www.recursionpharma.com/approach.html Recursion Pharmaceuticals]: Drug discovery using AI. $58M raised.
 *[http://benevolent.ai/about-us/ Benevolent.ai]: AI for drug discovery and bioscience innovation in general. $140M raised. UK based.
 *[http://www.gnshealthcare.com/our-approach/ GNS Healthcare]: Machine learning applied for precision medicine. Solutions around patient segmentation, drug discovery. $43M raised.